Erdafitinib is a medicine that helps with metastatic urothelial carcinoma, which is a type of cancer that spreads, especially when it’s tied to FGFR2/3 alterations. It works by going after FGFR signaling. You can get it in 3 mg, 4 mg, or 5 mg doses, all in a film-coated tablet form.
The usual starting dose is 8 mg taken once every day, but it can be adjusted to as much as 9 mg if needed. It comes in bottles, each holding 56 pills. This drug stops FGFR signaling, which is really important for dealing with some kinds of cancer.
Erdafitinib is meant to be taken by mouth. How well it works mostly depends on keeping the dose right. The tablets are coated so they’re easier to swallow and so the medicine stays safe from wearing down.
Reviews
There are no reviews yet.